National genomics board - Professor Sir John Bell, Wellcome Sanger Institute, Genetic Alliance, Cancer Research UK, Astrazeneca, GSK, UK Biobank, Our Future Health, Jillian Hastings Ward (Patient Representative), Genomics PLC, Nuffield Council on Bioethics, BioIndustry Association, Academy of Medical Royal Colleges

Names in the records

Each spelling a register uses for this entity, and the method that tied it here. A name is never the identity; a similar name is never a match.

What the records establish

• National genomics board - Professor Sir John Bell, Wellcome Sanger Institute, Genetic Alliance, Cancer Research UK, Astrazeneca, GSK, UK Biobank, Our Future Health, Jillian Hastings Ward (Patient Representative), Genomics PLC, Nuffield Council on Bioethics, BioIndustry Association, Academy of Medical Royal Colleges: 1 record of "recorded meeting with a minister" on 7 November 2023.

What this does not establish

The records above establish that National genomics board - Professor Sir John Bell, Wellcome Sanger Institute, Genetic Alliance, Cancer Research UK, Astrazeneca, GSK, UK Biobank, Our Future Health, Jillian Hastings Ward (Patient Representative), Genomics PLC, Nuffield Council on Bioethics, BioIndustry Association, Academy of Medical Royal Colleges and each entity named appear together in an official register, in the relationship that register records, on the date it records. They do not establish why any donation was made, why any contract was awarded, whether any one record was known to the people behind another, or that any record caused another. No causal inference is made on this page, and nothing here is a finding of any kind against anyone. A reported donation is a lawful, reported transaction; a contract award is a published notice; a seat is a seat.